# DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial

> **NCT05628532** · NA · COMPLETED · sponsor: **Diabeloop** · enrollment: 90 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Use of the DBLG1 system

## Key facts

- **NCT ID:** NCT05628532
- **Lead sponsor:** Diabeloop
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-03
- **Primary completion:** 2024-02-21
- **Final completion:** 2024-04-29
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05628532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05628532, "DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05628532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*